Publication Venue For
Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group.
Identifying provisional generic contextual factor domains for clinical trials in rheumatology: Results from an OMERACT initiative.
Rates of total joint replacement in the United States: Future projections to 2020-2040 using the national inpatient sample.
Factors Influencing the Effectiveness of Allopurinol in Achieving and Sustaining Target Serum Urate in the National Veterans Administration Gout Cohort.
Core domain Set selection according to OMERACT filter 2.1: The OMERACT methodology.
Establishing an updated core domain set for studies in juvenile idiopathic arthritis: A report from the OMERACT 2018 JIA workshop.
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT premeeting toward consensus on core sets for randomized controlled trials.
Instrument selection using the OMERACT filter 2.1: The OMERACT methodology.
OMERACT filter 2.1: Elaboration of the conceptual framework for outcome measurement in health intervention studies.
The Third Biennial 2018 OMERACT First-time Participant Program: A qualitative and quantitative study.
Uptake and Clinical Utility of Multibiomarker Disease Activity Testing in the United States..
HLA-DRB1 amino acid positions and residues associated with antibody-positive rheumatoid arthritis in black south africans.
Juvenile idiopathic arthritis: An idea whose time has gone?.
OMERACT Development of a Core Domain Set of Outcomes for Shared Decision-making Interventions.
Osteopontin and disease activity in patients with recent-onset systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
Predictors of achieving remission among patients with psoriatic arthritis initiating a tumor necrosis factor inhibitor.
Standardizing terminology and assessment for orofacial conditions in juvenile idiopathic arthritis: International, multidisciplinary consensus-based recommendations.
Risk factors for intraarticular heterotopic bone formation in the temporomandibular joint in Juvenile idiopathic arthritis.
Adiposity in juvenile psoriatic arthritis.
Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus.
Variability in the reporting of serum urate and flares in gout clinical trials: Need for minimum reporting requirements.
Trends in joint replacement surgery in patients with rheumatoid arthritis.
Comparative effectiveness of tumor necrosis factor agents and disease-modifying antirheumatic therapy in children with enthesitis-related arthritis: The first year after diagnosis.
Routine use of quantitative disease activity measurements among us rheumatologists: Implications for treat-to-target management strategies in rheumatoid arthritis.
Critical outcomes in longitudinal observational studies and registries in patients with rheumatoid arthritis: An OMERACT special interest group report.
Evidence for updating the core domain set of outcome measures for juvenile idiopathic arthritis: Report from a special interest group at OMERACT 2016.
Validating rheumatoid arthritis remission using the patients' perspective: Results from a special interest group at OMERACT 2016.
Achieving consensus on total joint replacement trial outcome reporting using the OMERACT filter: Endorsement of the final core domain set for total hip and total knee replacement trials for endstage arthritis.
Health equity considerations for developing and reporting patient-reported outcomes in clinical trials: A report from the omeract equity special interest group.
Isolated arthritis of the temporomandibular joint as the initial manifestation of juvenile idiopathic arthritis.
Engaging stakeholders and promoting uptake of OMERACT core outcome instrument sets.
Malignancy in pediatric-onset systemic lupus erythematosus.
The OMERACT first-time participant program: Fresh eye from the new guys.
Outcome measures used in arthroplasty trials: Systematic review of the 2008 and 2013 literature.
Longterm effectiveness of herpes zoster vaccine among patients with autoimmune and inflammatory diseases.
Weathering a macrophage storm.
Safety of biologic and nonbiologic disease-modifying antirheumatic drug therapy in veterans with rheumatoid arthritis and hepatitis c virus infection.
The effect of widespread pain on knee pain worsening, incident knee osteoarthritis (OA), and incident knee pain: The multicenter OA (MOST) study.
Attitudes and approaches for withdrawing drugs for children with clinically inactive nonsystemic JIA: A survey of the childhood arthritis and rheumatology research alliance.
Clinical orofacial examination in juvenile idiopathic arthritis: International consensus-based recommendations for monitoring patients in clinical practice and research studies.
The juvenile psoriatic arthritis cohort in the CARRA registry: Clinical characteristics, classification, and outcomes.
Adherence and persistence with methotrexate in rheumatoid arthritis: A systematic review.
Treatments for lupus nephritis: A systematic review and network metaanalysis.
The systemic juvenile idiopathic arthritis cohort of the childhood arthritis and rheumatology research alliance registry: 2010-2013.
Time trends, predictors, and outcome of emergency department use for gout: A nationwide US study.
Agreement between rheumatologist and patient-reported adherence to methotrexate in a US rheumatoid arthritis registry.
Prospecting for precision: Promises for personalized medicine.
Ms. A.M. Taylor, et al reply.
The performance and association between patient-reported and performance-based measures of physical functioning in research on individuals with arthritis.
Imaging as an outcome measure in gout studies: Report from the OMERACT gout working group.
Outcome domains and measures in total joint replacement clinical trials: Can we harmonize them? An OMERACT collaborative initiative.
Toward ensuring health equity: Readability and cultural equivalence of OMERACT patient-reported outcome measures.
Consensus on the need for a hierarchical list of patient-reported pain outcomes for metaanalyses of knee osteoarthritis trials: An OMERACT objective.
Current state of reporting pain outcomes in cochrane reviews of chronic musculoskeletal pain conditions and considerations for an OMERACT research agenda.
Harmonizing pain outcome measures: Results of the pre-OMERACT meeting on partnerships for consensus on patient-important pain outcome domains between the cochrane musculoskeletal group and OMERACT.
Is chronic pain a disease in its own right? Discussions from a pre-OMERACT 2014 workshop on chronic pain.
No association between daily walking and knee structural changes in people at risk of or with mild knee osteoarthritis. prospective data from the multicenter osteoarthritis study.
A call for evidence-based decision making when selecting outcome measurement instruments for summary of findings tables in systematic reviews: Results from an OMERACT working group.
An internet-based controlled trial aimed to improve osteoporosis prevention among chronic glucocorticoid users.
Barriers to medication decision making in women with lupus nephritis: A formative study using nominal group technique.
Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Do "evidence-based recommendations" need to reveal the evidence? Minimal criteria supporting an "evidence claim".
Does viral hemorrhagic fever represent reactive hemophagocytic syndrome?.
Is the double contour sign specific for gout? Or only for crystal arthritis?.
Magnetic resonance imaging findings following intraarticular infliximab therapy for refractory temporomandibular joint arthritis among children with juvenile idiopathic arthritis.
Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system.
Optimal strategies for reporting pain in clinical trials and systematic reviews: Recommendations from an OMERACT 12 workshop.
Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.
The OMERACT first-time participant ("Newbie") program: Initial assessment and lessons learned.
Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis.
Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors.
Continued benefit of tocilizumab plus disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis and inadequate clinical responses by week 8 of treatment.
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
Update of strategies to translate evidence from cochrane musculoskeletal group systematic reviews for use by various audiences.
Updated method guidelines for cochrane musculoskeletal group systematic reviews and metaanalyses.
American college of rheumatology criteria at inception, and accrual over 5 years in the slicc inception cohort.
Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout.
Changes in body mass index in children with juvenile idiopathic arthritis treated with tumor necrosis factor inhibitors.
Does clinically important change in function after knee replacement guarantee good absolute function? the multicenter osteoarthritis study.
How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
Including health equity considerations in development of instruments for rheumatology research: An introduction to a novel OMERACT paradigm.
Introduction: OMERACT 11 - International consensus conference on outcome measures in rheumatology clinical trials.
OMERACT endorsement of measures of outcome for studies of acute gout.
Outcome measures in acute gout: A systematic literature review.
Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: A multicenter study.
Research priorities in gout: The patient perspective.
Safety and efficacy of tofacitinib, an oral janus kinase inhibitor, for the treatment of rheumatoid arthritis in open-Label, longterm extension studies.
The diagnostic performance of anterior knee pain and activity-related pain in identifying knees with structural damage in the patellofemoral joint: The Multicenter Osteoarthritis Study.
Updating the OMERACT Filter: Core areas as a basis for defining core outcome sets.
Updating the OMERACT filter: Implications for imaging and soluble biomarkers.
Updating the omeract filter: Discrimination and feasibility.
Updating the omeract filter: Implications of filter 2.0 to select outcome instruments through assessment of "truth": Content, face, and construct validity.
Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis.
Challenges in defining quality of care for glucocorticoid-induced osteoporosis: Defending good against perfect.
High doses of infliximab in the management of juvenile idiopathic arthritis.
A Delphi exercise to identify characteristic features of gout - Opinions from patients and physicians, the first stage in developing new classification criteria (Journal of Rheumatology (2013) 40, (498-505)).
Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritis.
Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009.
Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: A cross-sectional analysis of the childhood arthritis and rheumatology research alliance (CARRA) registry.
Variable association of reactive intermediate genes with systemic lupus erythematosus in populations with different African ancestry.
Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: Results from the TEAR trial.
Higher-dose anakinra is effective in a case of medically refractory macrophage activation syndrome.
A Delphi exercise to identify characteristic features of gout - Opinions from patients and physicians, the first stage in developing new classification criteria.
Shrinking lung syndrome as a manifestation of pleuritis: A new model based on pulmonary physiological studies.
Comparative effectiveness of nonbiologic versus biologic disease-modifying antirheumatic drugs for rheumatoid arthritis.
Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: The Childhood Arthritis and Rheumatology Research Alliance Registry.
Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: A cross-sectional analysis of the CARRA registry.
Risk factors for temporomandibular joint arthritis in children with juvenile idiopathic arthritis.
Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial.
Genetic risk factors for thrombosis in systemic lupus erythematosus.
Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: Evidence from phase III randomized controlled trials.
Timing and magnitude of initial change in disease activity score 28 predicts the likelihood of achieving low disease activity at 1 year in rheumatoid arthritis patients treated with certolizumab pegol: A post-hoc analysis of the RAPID 1 trial.
Attainment of inactive disease status following initiation of TNF-α inhibitor therapy for juvenile idiopathic arthritis: Enthesitis-related arthritis predicts persistent active disease.
Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis.
Temporomandibular joint arthritis in pediatric Sjögren disease and sarcoidosis.
Smoking and outcomes after knee and hip arthroplasty: A systematic review.
Arthritis increases the risk for fractures - Results from the women's health initiative.
Developing a construct to evaluate flares in rheumatoid arthritis: A conceptual report of the OMERACT RA Flare Definition Working Group.
Bringing it all together: A novel approach to the development of response criteria for chronic gout clinical trials.
Consistency of knee pain and risk of knee replacement: The multicenter osteoarthritis study.
Early postoperative mortality following joint arthroplasty: A systematic review.
Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: A randomized controlled trial (The Journal of Rheumatology (2010) 37, (2377-86)).
Patient-reported outcomes in chronic gout: A report from OMERACT 10.
Serum urate in chronic gout - Will it be the first validated soluble biomarker in rheumatology?.
Tophus measurement as an outcome measure for clinical trials of chronic gout: Progress and research priorities.
Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: Post-hoc analysis of a randomized controlled trial.
An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Surgery for shoulder osteoarthritis: A cochrane systematic review.
Botulinum toxin for shoulder pain: A cochrane systematic review.
The functional polymorphism 844 A>G in Fc αRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility.
Disease phenotypes and gender association of FCRL3 single-nucleotide polymorphism -169T/C in Taiwanese patients with systemic lupus erythematosus and rheumatoid arthritis.
Combination therapy of abatacept and in children with refractory systemic juvenile idiopathic arthritis: A retrospective case series.
Tocilizumab for rheumatoid arthritis: A cochrane systematic review.
Intraarticular botulinum toxin A for refractory painful total knee arthroplasty: A randomized controlled trial.
Spondyloarthritis in a pediatric population: Risk factors for sacroiliitis.
Clinically important improvement in function is common in people with or at high risk of knee OA: The MOST study.
Golimumab for rheumatoid arthritis: A systematic review.
Effectiveness and toxicity of methotrexate in juvenile idiopathic arthritis: Comparison of 2 initial dosing regimens.
(Journal of Rheumatology (2009) 36, (2114) DOI:10.3899/jrheum.090591).
Abatacept for rheumatoid arthritis: A cochrane systematic review (Journal of Rheumatology (2010) 37, (234-245) DOI:10.3899/jrheum.091066).
Vitamin D status and its associations with disease activity and severity in african americans with recent-onset rheumatoid arthritis.
A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract.
Abatacept for rheumatoid arthritis: A cochrane systematic review.
Assessment of the methodologic quality of medical and surgical clinical trials in patients with arthroplasty.
What makes patients with fibromyalgia feel better? Correlations between patient global impression of improvement and changes in clinical symptoms and function: A pooled analysis of 4 randomized placebo-controlled trials of duloxetine.
Assessing single joints in arthritis clinical trials.
Discordance between self-report of physician diagnosis and administrative database diagnosis of arthritis and its predictors.
Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: A 12-month randomized, placebo-controlled clinical trial.
Anakinra for rheumatoid arthritis: A systematic review.
Spondyloarthritis is associated with poor function and physical health-related quality of life.
Cardiac magnetic resonance imaging with pharmacological stress perfusion and delayed enhancement in asymptomatic patients with systemic sclerosis.
Fibromyalgia, systemic lupus erythematosus (SLE), and evaluation of SLE activity.
How to ascertain drug safety in the context of benefit. Controversies and concerns.
Evaluation of an instrument assessing influence of gout on health-related quality of life.
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): LXI. Value of C-reactive protein as a marker of disease activity and damage.
A new approach yields high rates of radiographic progression in knee osteoarthritis.
Evaluation of the presentation of systemic onset juvenile rheumatoid arthritis: Data from the Pennsylvania Systemic Onset Juvenile Arthritis Registry (PASOJAR).
Neither cell-surface nor soluble CD154 levels are associated with coronary artery disease in systemic lupus erythematosus.
Does medical insurance matter in the progression to endstage renal disease among patients with lupus nephritis?.
Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: A survey of pediatric rheumatologists in the United States and Canada.
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
Juvenile idiopathic arthritis classification criteria: Loopholes and diagnosis software .
Benefit of intraarticular corticosteroid injection under fluoroscopic guidance for subtalar arthritis in juvenile idiopathic arthritis.
Interleukin 1 receptor antagonist to treat cytophagic histiocytic panniculitis with secondary hemophagocytic lymphohistiocytosis.
Trends in prevention of glucocorticoid-induced osteoporosis.
Septic abscess in a child with juvenile idiopathic arthritis receiving anti-tumor necrosis factor-α therapy .
Medication errors with the use of allopurinol and colchicine: A retrospective study of a national, anonymous internet-accessible error reporting system.
Treatment of pediatric localized scleroderma with methotrexate.
Patterns of use and public perception of over-the-counter pain relievers: Focus on nonsteroidal antiinflammatory drugs.
Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.
Pain-related beliefs and affective pain responses: Implications for ethnic disparities in preferences for joint arthroplasty.
Effect of ethnicity on disease activity in systemic lupus erythematosus  (multiple letters).
Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture.
Swallowing difficulties from "DISH-phagia".
The Systemic Lupus Activity Measure-Revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a Modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Effect of methotrexate therapy on bone mineral density and body composition in rat adjuvant arthritis.
Quantitative analysis of immunohistologic features of very early rheumatoid synovitis in disease modifying antirheumatic drug- and corticosteroid- naïve patients.
Recent Approaches to Understanding Osteoarthritis Pain.
Nonsteroidal Antiinflammatory Drug Toxicity Monitoring and Safety Practices.
A 2-Phase Screening Process for Patients with Wegener's Granulomatosis: A Pilot Study.
Health related quality of life in women with elderly onset rheumatoid arthritis.
OMERACT 6 brings new perspectives to rheumatology measurement research.
Balancing bones and bucks among new glucocorticoid users.
Normal radiographs in patients with persistent "hip pain" - Value of magnetic resonance imaging.
Significance of increased circulating proteasome in autoimmune disease.
Blood transfusion, alcohol use, and anthropometric risk factors for rheumatoid arthritis in older women.
Absence of linkage or association for osteoarthritis with the vitamin D receptor/type II collagen locus: The Framingham Osteoarthritis Study.
MTX affects inflammation and tissue destruction differently in the rat AA model.
Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort.
Women in rheumatology .
Occurrence of scleroderma in monozygotic twins.
The impact of women in the practice of academic and clinical rheumatology in the Americas.
Nabumetone induced pseudoporphyria in childhood  (multiple letters).
Nabumetone induced pseudoporphyria in childhood..
Comparison of nasal and oral tolerance for the prevention of collagen induced murine arthritis.
Radiographic assessment of disease progression in rheumatoid arthritis patients treated with methotrexate or minocycline.
Expression of the precursor of secretoneurin, secretogranin II, in the synovium of patients with rheumatoid arthritis and osteoarthritis.
Current treatment by United States and Canadian pediatric rheumatologists.
Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug  (multiple letters).
Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis.
Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: Disease remissions and changes in diagnoses in well established and undifferentiated CTD.
Self-administered joint counts in rheumatoid arthritis: Comparison with standard joint counts.
Paucity of radiographic progression in rheumatoid arthritis treated with methotrexate as the first disease modifying antirheumatic drug.
Folic acid supplementation prevents deficient blood  (multiple letters).
Familial painful restless legs syndrome correlates with pain dependent variation of blood flow to the caudate, thalamus, and anterior cingulate gyrus.
Enhanced expression of immunoglobulin κ light chains with unusually long CDR3 regions in patients with rheumatoid arthritis.
Septic arthritis caused by Neisseria sicca..
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: Implications for cardiovascular disease prevention.
Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: Disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases.
Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis.
A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial.
Treatment of rheumatoid joint inflammation with intrasynovial triamcinolone..
Childhood sarcoidosis--does age of onset predict clinical manifestations?.
Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) trial.
Folinic acid to prevent side effects of methotrexate in juvenile rheumatoid arthritis .
Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: Toxicity and dose finding trial in refractory rheumatoid arthritis.
Suppression of in vitro IgM rheumatoid factor production by diphtheria toxin interleukin 2 recombinant fusion protein (DAB 486IL-2) in patients with refractory rheumatoid arthritis.
Vβ17 T cell receptor peptide vaccination in rheumatoid arthritis: Results of phase I dose escalation study.
Systemic lupus erythematosus: Predictors of its occurrence among a cohort of patients with early undifferentiated connective tissue disease: Multivariate analyses and identification of risk factors.
Nonsteroidal antiinflammatory drugs and cognitive decline in the elderly.
Reiter's syndrome associated with cryptosporidial gastroenteritis.
Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus.
Arthroscopic evaluation of knee articular cartilage: A comparison with plain radiographs and magnetic resonance imaging.
Survival impact of autoantibodies in systemic lupus erythematosus.
Functional magnetic resonance imaging should be included in the evaluation of the cervical spine in patients with rheumatoid arthritis.
Meta analysis of the effect of methotrexate on radiologic progression in rheumatoid arthritis .
Anticardiolipin antibodies in systemic lupus erythematosus: Clinical correlates, HLA associations, and impact on survival.
Folic acid supplementation during methotrexate therapy: It makes sense.
Sternoclavicular brucellar arthritis: A report of 7 cases and a review of the literature.
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: A meta-analysis.
Digital subtraction radiography for the assessment of bone changes in rheumatoid arthritis.
Expressing our inner thoughts: How to organize and write a clinical research project grant application.
Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma.
Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma.
Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia.
Subcutaneous pancreatic fat necrosis associated with acute arthritis.
Disease and psychosocial factors related to physical functioning in rheumatoid arthritis.
Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease.
Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases.
Monthly cyclophosphamide in lupus pneumonitis and myositis.
Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?.
Activated lymphocytes in peripheral blood of patients with RA.
An eosinophilia-myalgia syndrome associated with an L-tryptophan containing product.
Eosinophilic myositis an expression of L-tryptophan toxicity?.
Mortality vs quality of life (I).
The value of the Norgaard view in the evaluation of erosive arthritis.
Cognitive-behavioral therapy for primary fibromyalgia.
Discriminant and convergent validity of self-report measures of affective distress in patients with rheumatoid arthritis.
Thrombotic thrombocytopenic purpura in systemic sclerosis..
AS and a 9.2 kb Pvu II class I HLA DNA restriction fragment..
Clinical characteristics affecting survival in patients with rheumatoid arthritis undergoing cervical spine surgery: A controlled study.
Lupus pneumonitis and anti-SSA(Ro) antibodies.
Methotrexate-induced liver abnormalities in rheumatoid arthritis.
Rheumatoid arthritis in American blacks: A clinical and radiological study.
Septic arthritis due to Mycobacterium phlei presenting as infantile Reiter's syndrome.
Severe reversible interstitial pneumonitis induced by low dose methotrexate.
Articular involvement in human brucellosis..
Etiopathogenesis of rheumatoid arthritis-like disease in MRL/1 mice: II. Ultrastructural basis of joint destruction.
The value of the joint alignment and motion scale in rheumatoid arthritis.
Transient osteoporosis of the hip: Magnetic resonance imaging.
The arthritis of brucellosis: a perspective one hundred years after Bruce's discovery..
The assessment of pain in rheumatoid arthritis: Disease differentiation and temporal stability of a behavioral observation method.
Sexual quality-of-life of patients with arthritis compared to arthritis-free controls.
Toxicity to methotrexate in rheumatoid arthritis.
Genetic and molecular genetic studies of murine and human lupus..
14 Suppl 13:166-176.
Toxicity due to remission inducing drugs in RA..
Development of clinical criteria for osteoarthritis.
Evaluation of the American Rheumatism Association preliminary criteria for remission in rheumatoid arthritis: A prospective study.
Meeting highlights: Workshop on epidemiology of the rheumatic diseases in the Americas.
Paracoccidioides brasiliensis arthritis. Report of a case and review of the literature.
The carpometacarpal ratio: A useful method for assessing disease progression in rheumatoid arthritis.
Study of HLA antigens in ten multiple-case rheumatoid arthritis families.
Immune complexes and clinical manifestations in patients with rheumatoid arthritis..
Local synthesis of IgM and IgM rheumatoid factor in rheumatoid pleuritis.
DR antigen distribution in blacks with rheumatoid arthritis.
Reactive arthritis associated with brucellosis: HAL studies.